DISORDER
DEFECT
FINDINGS
DIAGNOSIS · TREATMENT
Leukocyte adhesion deficiency 1
CD18 (β2 integrin), AR
Delayed umbilical cord separation, omphalitis, skin/mucosal infections without pus, periodontitis, neutrophilia
Flow: ↓ CD18 · HSCT
Chronic granulomatous disease
NADPH oxidase (gp91phox X-linked; p47phox AR)
Recurrent abscesses (skin, lung, liver, nodes), osteomyelitis, granulomas obstructing GI/GU tract
Abnormal DHR (NBT negative) · TMP-SMX, itraconazole, IFN-γ · HSCT
LYST, AR → microtubule/lysosomal trafficking failure
Recurrent pyogenic infections, partial oculocutaneous albinism, peripheral neuropathy, bleeding, HLH ("accelerated phase")
Giant granules in neutrophils · HSCT
Myeloperoxidase deficiency
MPO, AR; most common phagocyte defect
Usually asymptomatic; Candida infections (diabetes)
Normal DHR · absent MPO staining
Severe congenital neutropenia · cyclic neutropenia
ELANE and others
Severe bacterial infections, oral ulcers (cyclic every ~21 days)
G-CSF · leukemia risk
Early classical (C1q, C1r/s, C2, C4)
Poor immune-complex and apoptotic clearance
SLE-like disease, encapsulated infections
↓ CH50
No opsonization, no downstream activation
Severe recurrent pyogenic infections, immune-complex GN
↓ CH50 and AH50
No MAC
Recurrent Neisseria meningitidis and disseminated gonococcal infection
Meningococcal vaccines · same risk with eculizumab
C1 esterase inhibitor deficiency
AD; uncontrolled kallikrein → bradykinin
Hereditary angioedema: non-itchy swelling, abdominal pain attacks, laryngeal edema
↓ C4 · C1-INH concentrate, icatibant · no ACE inhibitors
Acquired PIGA mutation (GPI anchor)
PNH: intravascular hemolysis, thrombosis (hepatic veins), pancytopenia
Flow cytometry (FLAER) · eculizumab
Factor H · factor I deficiency
Uncontrolled alternative pathway
Atypical HUS, C3 glomerulopathy; ↓ C3
Eculizumab
Lectin pathway
Infections in infancy, usually mild
Common polymorphisms